1191997-64-4 Usage
Uses
Used in Pharmaceutical Industry:
(S)-2-(4-(2-chlorophenoxy)-2-oxo-2,5-dihydro-1H-pyrrol-1-yl)-4-methylpentanoic acid is used as a potential pharmaceutical agent for its structural features that are reminiscent of known drugs and bioactive molecules. (S)-2-(4-(2-chlorophenoxy)-2-oxo-2,5-dihydro-1H-pyrrol-1-yl)-4-methylpentanoic acid's specific arrangement of functional groups may confer it with therapeutic properties, although further research is necessary to elucidate its exact applications, mechanisms of action, and safety profile.
Given the compound's structural complexity and the presence of a pyrrole ring, which is a common structural motif in various biologically active compounds, it may have potential applications in the development of new drugs targeting specific receptors or enzymes. The 2-chlorophenoxy group could potentially influence the compound's lipophilicity, affecting its absorption, distribution, metabolism, and excretion (ADME) properties, which are critical considerations in drug design.
The 2-oxo group may also play a role in the compound's reactivity or its ability to form hydrogen bonds, which could be important for its interaction with biological targets. The 4-methylpentanoic acid group contributes to the overall hydrophobicity of the molecule, which might affect its solubility and pharmacokinetics.
Check Digit Verification of cas no
The CAS Registry Mumber 1191997-64-4 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,1,9,1,9,9 and 7 respectively; the second part has 2 digits, 6 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 1191997-64:
(9*1)+(8*1)+(7*9)+(6*1)+(5*9)+(4*9)+(3*7)+(2*6)+(1*4)=204
204 % 10 = 4
So 1191997-64-4 is a valid CAS Registry Number.
1191997-64-4Relevant academic research and scientific papers
Pyrrolidinone derivative as glucokinase activator and preparation method and application thereof
-
Paragraph 0129-0130; 0143-0144; 0147-0148; 0159-0160, (2021/10/13)
The invention provides a pyrrolidone derivative, and more specifically relates to a compound of the formula (I) or a pharmaceutically acceptable salt thereof, and a preparation method and application thereof. These compounds and contain their pharmaceutical compositions useful as glucokinase activators for the treatment of metabolic diseases and disorders. R1 . R2 , R3 , R4 , R5 , X And A are as described in the present invention.
Deuterated pyrrolidone derivative Pharmaceutical compositions and uses thereof
-
Paragraph 0065-0066; 0071, (2021/10/27)
The invention relates to a deuterated pyrrolidone derivative and a preparation method thereof, and also relates to application of the deuterated pyrrolidone derivative and a pharmaceutical composition thereof in treatment and prevention of metabolic disorder related diseases, and belongs to the field of medicines.
PYRROLIDINONE GLUCOKINASE ACTIVATORS
-
Page/Page column 57, (2009/10/30)
Provided herein are compounds of the formula (I): as well as pharmaceutically acceptable salts thereof, wherein the substituents are as those disclosed in the specification. These compounds, and the pharmaceutical compositions containing them, are useful for the treatment of metabolic diseases and disorders such as, for example, type II diabetes mellitus.
